Comparison of X-ray and alpha particle effects on a human cancer and endothelial cells: Survival curves and gene expression profiles

Résultats de recherche: Contribution à un journal/une revueArticle

1 Téléchargements (Pure)

Résumé

Background and purpose Tumours are now considered as complex tissues including endothelial cells of the tumour vasculature, which can decrease radiotherapy efficacy. It is thus important to better characterise the response of both types of cells to irradiation. This study investigated the effects of X-ray and alpha particle irradiation on cancer and endothelial cells. Materials and methods A549 non-small-cell lung adenocarcinoma cells and human endothelial cells (EC) were exposed to X-rays or alpha particles. Responses were studied by clonogenic assays and nuclei staining. A gene expression study was performed by using Taqman low density array and the results were validated by qRT-PCR and ELISA. Results The relative biological effectiveness of alpha particles was estimated to be 5.5 and 4.6 for 10% survival of A549 cells and EC, respectively. Nuclei staining indicated that mitotic catastrophe was the main type of cell death induced by X-rays and alpha particles. Both ionising radiations induced the overexpression of genes involved in cell growth, inflammation and angiogenesis. Conclusions Alpha particle irradiations are more effective than X-rays. The gene expression changes observed in both cell types after alpha particle or X-ray exposure showed possible crosstalk between both cell types that may induce the development of radioresistance.
langue originaleAnglais
Pages (de - à)397-403
Nombre de pages7
journalRadiotherapy and Oncology
Volume106
Numéro de publication3
Les DOIs
Etat de la publicationPublié - 2013

Empreinte digitale Examiner les sujets de recherche de « Comparison of X-ray and alpha particle effects on a human cancer and endothelial cells: Survival curves and gene expression profiles ». Ensemble, ils forment une empreinte digitale unique.

  • Équipement

    Génétique - génomique

    Karine Van Doninck (!!Manager)

    Plateforme technologique Genetique et genomique

    Equipement/installations: Plateforme technolgique

  • Activités

    • 1 Participation à une conférence, un congrès

    2nd BHTC workshop ; Hadrontherapy: from cell to patient

    Stéphane Lucas (Organisateur)

    23 mai 2014

    Activité: Types de Participation ou d'organisation d'un événementParticipation à une conférence, un congrès

    Contient cette citation